We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Pfizer Inc | NYSE:PFE | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.11 | 0.40% | 27.92 | 27,279 | 11:25:05 |
From May 2021 to May 2024
By Cecilia Butini
The European Medicines Agency said Tuesday that its committee for human medicines has approved two additional manufacturing sites for the production of the coronavirus vaccine developed by BioNTech SE and Pfizer Inc.
The sites are in Reinbek, Germany, and Stein, Switzerland, and are operated by Allergopharma GmbH & Co. KG. and Novartis Pharma, respectively.
The sites are to become operational immediately, the agency said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
June 22, 2021 09:08 ET (13:08 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Pfizer Chart |
1 Month Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
